Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • New for 2026! CCAS QI/Education Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

QOW 437

Author: Sana Ullah, MB ChB, FRCA – Dallas, TX


An 8-month-old male infant is status post repair of a large perimembranous ventricular septal defect (VSD). After separation from cardiopulmonary bypass, the patient has the following vital signs: heart rate 130, blood pressure 80/45, and pulse oximetry 99% with a fractional inspired oxygen (FiO2) of 0.25. The post-repair transesophageal echocardiogram (TEE) reveals a small residual VSD. In order to determine if the VSD is hemodynamically significant, the surgeon samples blood from the superior vena cava (SVC) and the main pulmonary artery (PA), resulting in oxygen saturations of 60% and 80% respectively. What is the Qp:Qs?

Correct! Wrong!

EXPLANATION


Small residual ventricular septal defects (VSDs) are common after surgical repair and the decision to return to bypass is sometimes be difficult. The decision is based on TEE findings, direct pressure measurements in the right ventricle and PA, and a determination of the magnitude of the shunt by calculating the Qp:Qs ratio – where Qp is the pulmonary blood flow and the Qs is the systemic blood flow. The standard equation to calculate shunts in the cardiac catheterization laboratory is:


Qp:Qs = SaO2 – SmvO2 / SpvO2 – SpaO2


In this equation, SaO2 is the systemic arterial saturation, SmvO2 represents the mixed venous saturation, SpvO2 is pulmonary vein saturation, and SpaO2 is the pulmonary artery saturation. In the absence of an intracardiac shunt, the mixed venous saturation is sampled from the main pulmonary artery. However, in patients with left to right intracardiac shunts, the superior vena cava saturation more accurately reflects a true mixed venous saturation. In patients without an underlying pulmonary pathology, the pulmonary vein saturation is assumed to be 100% and thus equal to the systemic arterial saturation. To avoid a confounding impact of dissolved oxygen, blood samples should be taken at a low FiO2 of approximately 0.25-0.3. Therefore, in the operating room, the above equation can be simplified to:


Qp:Qs = SaO2 – SmvO2 / SaO2 – SpaO2


Substituting the data from the stem into this equation results in a Qp:Qs of 2:1. A Qp:Qs of more than 1.5-2:1 should prompt a return to bypass and revision of the repair. Although most residual VSDs are not hemodynamically significant and are likely to close over time, some studies have shown defects larger than three millimeters in diameter should be addressed surgically, which requires another period of cardioplegic arrest. Interestingly, a recent publication in the Annals of Translational Medicine by Cao et al has reported successful repair of residual VSDs on cardiopulmonary bypass but after aortic unclamping and with a beating heart. They reported good outcomes with no apparent complications. This strategy may represent an unnecessary risk for air embolism to the cerebral and coronary circulation.


REFERENCES


1. Joffe DC, Shi MR, Welker CC. Understanding cardiac shunts. Pediatr Anesth. 2018; 28:316-325. doi.org/10/1111/pan.11347


2. Bibevski S, Ruzmetov M, Mendoza L et al. The destiny of postoperative residual ventricular septal defects after surgical repair in infants and children. World J Pediatr Congenit Heart Surg .2020; 11: 438-443.


3. Cao Z, Chai Y, Liu J et al. Revising ventricular septal defect residual shunts without aortic re-cross-clamping: a safe and effective surgical procedure. Ann Transl Med . 2020; 8 (18): 1134. doi: 10.21037/atm-20-5041


Poll of the Month

May 2025
At your institution, do you routinely send a TEG/ROTEM during the rewarming phase of cardiopulmonary bypass?
View Results
Total Answers 78
Total Votes 78

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy